Cao Sean Wuxiong bought NBP
September 3, 2026 · Form 4 insider transaction
Cao Sean Wuxiong bought 104,236 shares of NovaBridge Biosciences, a transaction worth N/A. The trade was recorded as option exercise and disclosed on an SEC Form 4, filed 5 days after the transaction.
Direction
Acquired (buy-side)
Shares
104,236
Price
N/A
Total value
N/A
InsiderCao Sean Wuxiong
RoleOfficer, Director
CompanyNovaBridge Biosciences (NBP)
SecurityOrdinary Shares
Transaction codeM: Option exercise
Transaction dateSeptember 3, 2026
Filing dateSeptember 8, 2026
Shares owned after374,445
OwnershipDirect
10b5-1 planNo
AmendedNo
Footnotes
The Ordinary Shares may be represented by American Depositary Shares ("ADS"). Each 10 ADSs represent 23 Ordinary Shares of the Issuer.; Reported securities are represented by 45,320 ADSs.; Each restricted stock unit ("RSU") represents a contingent right to receive one ADS.